As the COVID-19 outbreak is rapidly evolving, IBD specialists from
all over the world have been challenged to face the
pandemic and address the specific issues of their patients, particularly
regarding the risk of infection and immunosuppressive treatment. This review
aims to sum- marize the best available evidence and expert
opinion in the field of IBD and COVID-19 outbreak.